Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
AdiCyte
AddedFeb 16, 2024
UpdatedJun 18, 2026
AdiCyte

AdiCyte

Seed

AdiCyte: Premier cryobank preserving adipose tissue & stem cells for future medical & cosmetic use.

HQ
Tucson, AZ, US
Founded
2011
Overview
Compare
Fundraising
Employees

Founded with the mission to advance regenerative medicine, AdiCyte is a leading cryobank specializing in the preservation of adipose tissue and stem cells. The company enables patients to store their collected adipose tissue and stem cells for future use in various medical and cosmetic procedures, including wrinkle treatments, augmentation, reconstructive surgeries, and cellular regenerative medicine. AdiCyte primarily serves patients undergoing liposuction, abdominoplasty, breast reduction, and microlipoinjection.

AdiCyte has established itself as a key player in the field of regenerative medicine through its innovative cryopreservation services. The company collaborates with top medical professionals and institutions to ensure the highest standards of tissue preservation. Notable achievements include successful partnerships with leading cosmetic and reconstructive surgeons, contributing significantly to advancements in regenerative treatments. AdiCyte's impact is evident in its role in enabling personalized medical solutions and enhancing patient outcomes in both cosmetic and therapeutic contexts.

AdiCyte - Similar Companies

American CryoStem logo

American CryoStem

StemSave logo

StemSave

stemsave.com

Personalized Stem Cells logo

Personalized Stem Cells

Celltex Therapeutics logo

Celltex Therapeutics

celltexbank.com

Stem Cell Reserve logo

Stem Cell Reserve

Stemcyte logo

Stemcyte

stemcyte.com

Next Healthcare logo

Next Healthcare

Acorn Biolabs logo

Acorn Biolabs

acorn.me

RhinoCyte logo

RhinoCyte

rhinocyte.com

MyCordBank.com logo

MyCordBank.com

mycordbank.com

Zhongyuan Union Cell & Gene Eng logo

Zhongyuan Union Cell & Gene Eng

Tissue Genesis logo

Tissue Genesis

tissuegenesis.com

Forever Labs logo

Forever Labs

foreverlabs.com

Biosculpture Technology logo

Biosculpture Technology

Stemedica Cell Technologies logo

Stemedica Cell Technologies

stemedica.com

AdiCyte - Quick Facts

Who are AdiCyte's competitors?

Companies similar to AdiCyte include American CryoStem, StemSave, Personalized Stem Cells and Celltex Therapeutics.

When was AdiCyte founded?

AdiCyte was founded in 2011.

Where is AdiCyte's headquarters located?

AdiCyte's headquarters is located in Tucson, AZ, US.

When was AdiCyte's last funding round?

AdiCyte's most recent funding round was for $1.5M (USD) in March 2013.

How much has AdiCyte raised to-date?

As of Mar 12, 2013, AdiCyte has raised a total of $2.6M (USD).

How many employees does AdiCyte have?

AdiCyte has 30 employees as of Feb 5, 2024.

AdiCyte - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Cryobanking
  • Stem Cells
Tags
  • Healthtech
  • Storage
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified